Stocks
Affimed (AFMD) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 117% | 2 117% | 14 197% | 14 197% | 2 546% | 10 470% | |||
| Changes by years, y/y, % | -9 245pp | 0pp | +12 081pp | 0pp | -11 651pp | -12.2% | |||
Affimed. R&D/CAPEX, %
Affimed. R&D/CAPEX, changes, pp
Affimed (AFMD) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 3 665% | 1 539 100% | 1 539 100% | 61 721% | 202 720% | 10 470% | ||
| Changes by years, y/y, % | -4 643pp | -780 712pp | +202 050pp | |||||
| Changes by quarters, q/q, % | +2 995pp | +1 535 435pp | 0pp | -1 477 379pp | +140 999pp | |||
